NCT03926260View on ClinicalTrials.gov

Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 27, 2019

Primary Completion Date

July 30, 2021

Study Completion Date

May 23, 2022

Conditions
Metastatic Non-small Cell Lung Cancer
Interventions
OTHER

ctDNA analysis

blood sample at Baseline, 3weeks, 9 weeks after treatment, at progression if applicable

Trial Locations (2)

44000

Jaafar BENNOUNA, Nantes

85000

Marie MARCQ, La Roche-sur-Yon

All Listed Sponsors
lead

Centre Hospitalier Departemental Vendee

OTHER

NCT03926260 - Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA | Biotech Hunter | Biotech Hunter